Hangzhou Boya Biopharmaceutical Overview
- Year Founded
-
2023
- Status
-
Private
- Latest Deal Type
-
Corporate
- Latest Deal Amount
-
$1.51M
- Investors
-
2
Hangzhou Boya Biopharmaceutical General Information
Description
Developer of commercial-stage pharmaceutical products designed to advance treatments for immune-mediated diseases and cancer. The company offers integrated capabilities in antibody engineering, clinical development, and large-scale manufacturing, enabling healthcare providers and patients access to high-quality biologics and innovative therapies.
Contact Information
Corporate Office
- Room 1602, North Building, Gongyuan Building, Lingyin Street
- Xihu District
- Hangzhou, Zhejiang 310000
- China
Corporate Office
- Room 1602, North Building, Gongyuan Building, Lingyin Street
- Xihu District
- Hangzhou, Zhejiang 310000
- China
Hangzhou Boya Biopharmaceutical Timeline
Hangzhou Boya Biopharmaceutical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Corporate | 24-Apr-2025 | $1.51M | Completed | Generating Revenue | ||
| 1. Seed Round | 07-Apr-2024 | Completed | Startup |
Hangzhou Boya Biopharmaceutical Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Jiangxi Synergy Pharmaceutical | Corporation | Minority | ||
| Thunderstorm Investment | Growth/Expansion | Minority |
Hangzhou Boya Biopharmaceutical FAQs
-
When was Hangzhou Boya Biopharmaceutical founded?
Hangzhou Boya Biopharmaceutical was founded in 2023.
-
Where is Hangzhou Boya Biopharmaceutical headquartered?
Hangzhou Boya Biopharmaceutical is headquartered in Hangzhou, China.
-
What industry is Hangzhou Boya Biopharmaceutical in?
Hangzhou Boya Biopharmaceutical’s primary industry is Pharmaceuticals.
-
Is Hangzhou Boya Biopharmaceutical a private or public company?
Hangzhou Boya Biopharmaceutical is a Private company.
-
What is Hangzhou Boya Biopharmaceutical’s current revenue?
The current revenue for Hangzhou Boya Biopharmaceutical is .
-
Who are Hangzhou Boya Biopharmaceutical’s investors?
Jiangxi Synergy Pharmaceutical and Thunderstorm Investment have invested in Hangzhou Boya Biopharmaceutical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process